跳至主要内容
临床试验/NL-OMON52231
NL-OMON52231招募中2 期

Boosting the endocannabinoid system before the treatment of anxiety symptoms - BOOSTCAMP

niversitair Medisch Centrum Utrecht0 个研究点目标入组 82 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
82

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • Dutch uniformed personnel (i.e. (former) police officers, firefighters,
  • ambulance paramedics, military personnel or veterans
  • Age between 18-65
  • Waiting for therapy for the treatment of a trauma and stressor-related and/or
  • an anxiety disorder

排除标准

  • Severe co-morbidity (severe major depressive or bipolar disorder and/or
  • Alcohol and/or drug dependence
  • Inability to adequately read or speak Dutch
  • (a history of) epilepsy or brain damage, cardiac, renal or liver abnormalities
  • (a history of) allergies to medication (adverse reactions or rash)
  • Individuals taking certain medications known to have potential interactions
  • with CBD (i.e., steroids, HMG-CoA reductase inhibitors, calcium channel
  • blockers, antihistamines, antivirals, immune modulators, benzodiazepines,
  • anti-arrhythmic, antibiotics, anesthetics, antipsychotics, antidepressants,
  • anti-epileptics, beta blockers, proton pump inhibitors, NSAIDs, angiotensin II
  • blockers, oral hypoglycemic agents, and sulfonylureas)
  • Used cannabis, synthetic cannabinoid, cannabinoid analogue, or any CBD or
  • THC-containing product within 30 days of eligibility screening.
  • Individuals that had been diagnosed with intestinal, liver, or renal diseases
  • that would affect absorption or clearance of CBD
  • For women: pregnant, a wish to become pregnant, or nursing

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

Boosting the endocannabinoid system before the... | 临床试验